Managing Director Drug Strategy & Business Development
Express Scripts
Warrendale, PA
Jeremy Fredell has been working within the PBM industry for over 20 years. In the role of Drug Strategy & Business Development, he will focus on drug classes that are key to ongoing client and organizational success to ensure a unified strategy across multiple stakeholders, inclusive of cohesive formulary and utilization management solutions. Prior responsibilities have included three years with Ascent Health Services in Schaffhausen, Switzerland, overseeing the strategy of commercial Utilization Management, contributing to the development of SafeGuard Rx programs, developing solutions in partnership with ESI national formularies, building a medical rebate offering, and several clinical roles with a focus on concurrent DUR and pharmacist education.
Jeremy has developed and presented numerous pharmacist continuing education programs, created specialized cardiovascular safety alerts to grow Therapeutic Resource Center reach, expanded the abilities and utilization of electronic prior authorization, and partnered in the creation of the Advanced Opioid Management solution. Additionally, he has been able to present at several Institute for Clinical and Economic Review (ICER) panels, AMCP Partnership Forum, PCMA, and the ESI Pharma Summit.
Thursday, October 13, 2022
2:45 PM – 4:00 PM ET